Representatives from Hokkaido University in the fields of life sciences and biotechnology will share the University’s latest research achievements and technological innovations to explore the partnering opportunities including patent licensing and collaborative research with excellent companies worldwide. 
Through participation in BIO-Europe Spring 2026, Hokkaido University seeks to further promote international research synergies and contribute to the advancement of biopharmaceutical science and innovation. 

 

1.GFRα1: A First-in-Class Lead for Functional CNS and PNS Nerve Regeneration
2.9-19: A Primate-Validated, Brain-Penetrant Mitochondrial Activator for AD
3.Targeted RNA Chaperones: A Precise Mechanism to Protect Motor Neurons in ALS
4.NET Inhibitors: Accelerating Acute Nerve Repair via the MIF/CXCR4 Axis
11. srRNA: A Stable, Vector-Based Alternative for Exon-Skipping Therapies
12. PIECE Platform Technology targeting Intracellular IL-6 for Tumor Therapeutics
13. Anti-IL-34 mAbs: Strategic Add-ons to Overcome Therapeutic Resistance
14. DCA-Micelles: A Precision Metabolic Radiosensitizer for Local Tumor Control

15. Alternative MoA Antibodies for ATL and Burkitt Lymphoma
16. Sequence-Specific BATF–IRF4–JUN Binding Assay for High-Throughput Screening
17. Epigenetic Modulator for Refractory GVHD and IBD
18. Next-Gen STING Agonists: Converting Cold Tumors via Potent Systemic Activation
19. STAP-1 Peptides: Selective T-Cell Modulation for Precision Autoimmune Therapy
20. CD28-NKG2D Chimeric Receptors: Overcoming Exhaustion in Solid Tumor CAR-T
21. Meflin: A Novel Biomarker and Therapeutic Target for Systemic Inflammation
22. IL-34-Induced Macrophages: Autologous Cell Therapy for Advanced Liver Cirrhosis

23. Resolvin E3 Indoles: A Pro-Resolving Approach for Insulin Resistance
24. Syk Inhibitors: A Safety Bridge for Post-Denosumab Transition in Osteoporosis
25. BDNF-Inducing Peptides: A Neuroprotective Approach for Glaucoma Treatment, Complementing IOP-lowering therapy
27. Neutralizing mAbs for Marburg Virus: High-Potency Outbreak Control Tools
28. Universal Pan-Species Ebola Antibodies: A Cross-Neutralizing Therapeutic Lead
29. Nemuri-Derived Peptides: A New Line of Defense Against MDR Bacterial Pathogens
30. 2-thiouridine (s2U): A Broad-Spectrum Antiviral for Positive-Strand RNA Viruses
34. MITO-Porter & CRISPR/Cas9: An Advanced Platform for Mitochondrial Gene Editing

5. HSC-Targeted LNPs: A Precision Delivery Platform for Reversing Hepatic Fibrosis
6. Spleen-Specific LNPs: Optimized Dendritic Cell Delivery for Next-Gen Vaccines
7. Helper Lipids: A Potency-Boosting Solution for Enhanced Endosomal Escape
8. Novel ζ-Lipids for Cas9 RNP Delivery: 98% Gene Knockout in vivo
9. NK Cell-Specific LNPs: Scalable Genetic Modification for Cold Tumor Therapy
10. Novel Cationic Lipids for Extrahepatic Delivery

31. Enhanced Mammalian Cell Vectors: High-Yield Production of Bio-Active Proteins
32. Micro-Scale SAR Platform: Rapid Structure-Optimization for Peptide Leads
33. Nonribosomal Peptide Cyclases: A High-Throughput Engine for Cyclic Peptide Discovery

38. IgA N-Glycan Markers: A Non-Invasive Diagnostic Tool for MASH Fibrosis Stages
39. HD5 Diagnostic Kits: Precision Monitoring for Intestinal Health and Microbiome
40. Portable Parasite NGS: A Field-Ready Comprehensive Detection System
41. Ultra-Sensitive Immunoassay Platform Using Advanced Optical Sensing

42. Non-Invasive taVNS Device: A Neuromodulation Strategy for Interstitial Pneumonia
43. Biomimetic Artificial Cartilage Implant for Durable Joint Repair
44. Cation-π Polymer Embolic Agent: Safe, Injectable, and Stable Vessel Occlusion
45. Attachment for Microscope Objective Lenses and Microscope

35. Bioluminescent BLI Mice: Real-Time evaluation for Reproductive Toxicity
36. Canine Anti-PD-L1: A Checkpoint Inhibitor Candidate for Veterinary Oncology
37. A Novel Anti-Feline PD-L1 Antibody as a Companion Diagnostic for Feline Cancer Immunotherapy